Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma

NCT04173338 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Closed by IRB on 3/28/22

Conditions

Non Small Cell Lung Cancer
Non-squamous Non-small-cell Lung Cancer
Urothelial Carcinoma
Malignant Mesothelioma

Interventions

DRUG: Cabozantinib
DRUG: Pemetrexed

Sponsor

Augusta University